HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Garcia-Porrua Selected Research

Carlos Garcia-Porrua Research Topics

Disease

9Rheumatoid Arthritis
01/2019 - 06/2002
9Giant Cell Arteritis (Horton Disease)
01/2006 - 08/2003
8Purpura
01/2006 - 05/2002
5Atherosclerosis
01/2012 - 06/2004
4Inflammation (Inflammations)
02/2007 - 09/2005
3Nephritis
01/2006 - 05/2002
3Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
12/2003 - 03/2002
3Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
10/2002 - 05/2002
2Vasculitis (Vasculitides)
06/2006 - 05/2002
2Disease Susceptibility (Diathesis)
12/2004 - 08/2003
2Erythema Nodosum
02/2004 - 08/2002
2Vascular Skin Diseases
02/2004 - 11/2002
1Meningitis
02/2012
1Rheumatoid Vasculitis
02/2006
1Hypoalbuminemia
09/2005
1Anemia
09/2005
1Pathologic Constriction (Stenosis)
09/2005
1Thrombocytosis (Thrombocythemia)
09/2005
1Stroke (Strokes)
09/2005
1Fever (Fevers)
08/2004
1Stress Fractures (Stress Fracture)
12/2003
1Tubulointerstitial nephritis and uveitis
10/2002
1Leukocytosis (Pleocytosis)
10/2002
1Uveitis
10/2002
1Sarcoidosis (Schaumann Disease)
08/2002
1Nephrotic Syndrome (Syndrome, Nephrotic)
07/2002
1Renal Insufficiency (Renal Failure)
07/2002

Drug/Important Bio-Agent (IBA)

6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 06/2004
6HLA-DRB1 Chains (HLA DRB1)IBA
02/2007 - 05/2002
2Biomarkers (Surrogate Marker)IBA
02/2007 - 09/2005
2C-Reactive ProteinIBA
02/2007 - 07/2005
2SteroidsIBA
06/2006 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 09/2005
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2005 - 06/2005
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2005 - 06/2005
2Macrophage Migration-Inhibitory FactorsIBA
01/2005 - 08/2002
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
02/2004 - 09/2003
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2004 - 03/2002
2EpitopesIBA
06/2003 - 06/2002
1Biological ProductsIBA
01/2019
1CalciumIBA
02/2012
1Adalimumab (Humira)FDA Link
01/2012
1Antirheumatic Agents (DMARD)IBA
01/2012
1CytokinesIBA
12/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2006
1Alkaline PhosphataseIBA
09/2005
1Hemoglobins (Hemoglobin)IBA
09/2005
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
08/2005
1Indicators and Reagents (Reagents)IBA
07/2005
1InterferonsIBA
12/2004
1Interleukin-4 (Interleukin 4)IBA
12/2004
1Interferon-gamma (Interferon, gamma)IBA
12/2004
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2004
1InterleukinsIBA
02/2004
1Interleukin-1beta (Interleukin 1 beta)IBA
02/2004
1Pharmaceutical PreparationsIBA
12/2003
1Genetic Markers (Genetic Marker)IBA
08/2003
1HLA-DRB1*04 antigenIBA
06/2003
1Corticotropin-Releasing HormoneIBA
05/2003
1Peptides (Polypeptides)IBA
11/2002
1Interleukin-8 (Interleukin 8)IBA
11/2002
1Chemokine CCL5IBA
11/2002
1Orlistat (Xenical)FDA Link
10/2002
1Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2002
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2002
1HLA Antigens (Human Leukocyte Antigens)IBA
06/2002
1HLA-B Antigens (HLA-B)IBA
05/2002
1HLA-B35 Antigen (HLA B35 Antigen)IBA
05/2002

Therapy/Procedure

6Therapeutics
01/2012 - 10/2002